Submitted by Anonymous (not verified) on 5 October 2023 - 13:41
Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Obesity;Overweight, Date of authorisation: 23/03/2015, Revision: 14, Status: Authorised
Source: